PAC-CI - Publications

Publications

Titre, auteurs, journal, résumé : :

Catégorie :

Année :

Epidemiology of travel-associated dengue from 2007 to 2022: A GeoSentinel analysis

Auteurs : 18. Duvignaud A, Stoney RJ, Angelo KM, Chen LH, Cattaneo P, Motta L, Gobbi FG, Bottieau E, Bourque DL, Popescu CP, Glans H, Asgeirsson H, Oliveira-Souto I, Vaughan SD, Amatya B, Norman FF, Waggoner J, Díaz-Menéndez M, Beadsworth M, Odolini S, Camprubí-Ferrer D, Epelboin L, Connor BA, Eperon G, Schwartz E, Libman M, Malvy D, Hamer DH, Huits R, GeoSentinel Network

2024

Journal : J Travel Med 31(7):taae089

Voir l’article

HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre longitudinal study (DTG RESIST)

Auteurs : 19. Egger M, Sauermann M, Loosli T, Hossmann S, Riedo S, Beerenwinkel N, Jaquet A, Minga A, Ross JL, Giandhari J, Kouyos R, Lessells R

2024

Journal : medRxiv :2024.05.23.24307850

Voir l’article

Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial

Auteurs : 20. Eholie SP, Ekouevi DK, Chazallon C, Charpentier C, Messou E, Diallo Z, Zoungrana J, Minga A, Ngom Gueye NF, Hawerlander D, Dembele F, Colin G, Tchounga B, Karcher S, Le Carrou J, Tchabert-Guié A, Toni T, Ouédraogo A-S, Bado G, Toure Kane C, Seydi M, Poda A, Mensah E, Diallo I, Drabo YJ, Anglaret X, Brun-Vezinet F, FIT-2 study group

2024

Journal : Lancet HIV 11(6):e380–e388

Voir l’article

Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries

Auteurs : 1. Aghokeng AF, Ngo-Giang-Huong N, Huynh THK, Dagnra AY, D’Aquin Toni T, Maiga AI, Dramane K, Eymard-Duvernay S, Chaix M-L, Calvez V, Descamps D

2024

Voir l’article

Publications

Publications

Epidemiology of travel-associated dengue from 2007 to 2022: A GeoSentinel analysis

HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre longitudinal study (DTG RESIST)

Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial

Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries

Contacts

Liens rapides

Suivez-nous sur